733
Views
21
CrossRef citations to date
0
Altmetric
Reviews

The pharmacogenetics of antimalaria artemisinin combination therapy

&
Pages 1185-1200 | Published online: 08 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karol J Marwa, Anthony Kapesa, Erasmus Kamugisha & Göte Swedberg. (2023) The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review. Pharmacogenomics and Personalized Medicine 16, pages 449-461.
Read now
Leyre Pernaute-Lau, Mahamadou Camara, Taís Nóbrega de Sousa, Ulrika Morris, Marcelo Urbano Ferreira & José Pedro Gil. (2022) An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology 18:1, pages 39-59.
Read now

Articles from other publishers (19)

Karol J Marwa, Anthony C Liwa, Eveline T Konje, Stanley Mwita, Erasmus Kamugisha & Göte Swedberg. (2022) Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania. International Journal of Infectious Diseases 123, pages 192-199.
Crossref
Meng Chen, Shu-yi Zhou, Erlinda Fabriaga, Pian-hong Zhang & Quan Zhou. (2018) Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review. Journal of Food and Drug Analysis 26:2, pages S61-S71.
Crossref
Kinanga Kiaco, António Sebastião Rodrigues, Virgílio do Rosário, José Pedro Gil & Dinora Lopes. (2017) The drug transporter ABCB1 c.3435C>T SNP influences artemether–lumefantrine treatment outcome. Malaria Journal 16:1.
Crossref
Ritah F. Mutagonda, Appolinary A. R. Kamuhabwa, Omary M. S. Minzi, Siriel N. Massawe, Muhammad Asghar, Manijeh V. Homann, Anna F?rnert & Eleni Aklillu. (2017) Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Malaria Journal 16:1.
Crossref
Karin Vos, Carlotta Lo Sciuto, Rita Piedade, Michael Ashton, Anders Björkman, Billy Ngasala, Andreas Mårtensson & José Pedro Gil. (2017) MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy . Pharmacogenomics 18:10, pages 981-985.
Crossref
E. Elliot, T. Mahungu & A. Owen. 2017. Genetics and Evolution of Infectious Diseases. Genetics and Evolution of Infectious Diseases 435 457 .
. 2016. Molecular Microbiology. Molecular Microbiology 613 633 .
Patricia R. Slev & David R. Hillyard. 2016. Molecular Pathology in Clinical Practice. Molecular Pathology in Clinical Practice 291 300 .
Karol J Marwa, Theresa Schmidt, Maria Sjögren, Omary MS Minzi, Erasmus Kamugisha & Göte Swedberg. (2014) Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations. Malaria Journal 13:1.
Crossref
Ar Kar Aung, David W Haas, Todd Hulgan & Elizabeth J Phillips. (2014) Pharmacogenomics of antimicrobial agents. Pharmacogenomics 15:15, pages 1903-1930.
Crossref
Dominic Mosha, Monia Guidi, Felista Mwingira, Salim Abdulla, Thomas Mercier, Laurent Arthur Decosterd, Chantal Csajka & Blaise Genton. (2014) Population Pharmacokinetics and Clinical Response for Artemether-Lumefantrine in Pregnant and Nonpregnant Women with Uncomplicated Plasmodium falciparum Malaria in Tanzania. Antimicrobial Agents and Chemotherapy 58:8, pages 4583-4592.
Crossref
Thierry Rolling, Tsiri Agbenyega, Saadou Issifou, Ayola Akim Adegnika, Justice Sylverken, Dorothee Spahlinger, Daniel Ansong, Sascha J. Z. Löhr, Gerd D. Burchard, Jürgen May, Benjamin Mordmüller, Sanjeev Krishna, Peter G. Kremsner & Jakob P. Cramer. (2014) Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study. The Journal of Infectious Diseases 209:12, pages 1921-1928.
Crossref
Sanjeev Krishna & Peter Gottfried Kremsner. (2013) Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends in Parasitology 29:7, pages 313-317.
Crossref
Alba G. Blazquez, Manuel Fernandez-Dolon, Laura Sanchez-Vicente, Alba D. Maestre, Ana B. Gomez-San Miguel, Marcelino Alvarez, Maria A. Serrano, Herwig Jansen, Thomas Efferth, Jose J.G. Marin & Marta R. Romero. (2013) Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis. Bioorganic & Medicinal Chemistry 21:14, pages 4432-4441.
Crossref
JP Gil. (2013) Malaria pharmacogenomics: return to the future. Pharmacogenomics 14:7, pages 707-710.
Crossref
Eva Maria Staehli Hodel, Chantal Csajka, Frédéric Ariey, Monia Guidi, Abdunoor Mulokozi Kabanywanyi, Socheat Duong, Laurent Arthur Decosterd, Piero Olliaro, Hans-Peter Beck & Blaise Genton. (2013) Effect of Single Nucleotide Polymorphisms in Cytochrome P450 Isoenzyme and N -Acetyltransferase 2 Genes on the Metabolism of Artemisinin-Based Combination Therapies in Malaria Patients from Cambodia and Tanzania . Antimicrobial Agents and Chemotherapy 57:2, pages 950-958.
Crossref
Ripudaman K. Bains. (2013) African variation at Cytochrome P450 genes. Evolution, Medicine, and Public Health 2013:1, pages 118-134.
Crossref
P. Byakika-Kibwika, M. Lamorde, V. Okaba-Kayom, H. Mayanja-Kizza, E. Katabira, W. Hanpithakpong, N. Pakker, T. P. C. Dorlo, J. Tarning, N. Lindegardh, P. J. de Vries, D. Back, S. Khoo & C. Merry. (2012) Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy 67:5, pages 1217-1223.
Crossref
Rita Piedade, Elke Schaeffeler, Stefan Winter, Sara Asimus, Matthias Schwab, Michael Ashton, Oliver Burk & José P. Gil. (2012) PXR Variants and Artemisinin Use in Vietnamese Subjects: Frequency Distribution and Impact on the Interindividual Variability of CYP3A Induction by Artemisinin . Antimicrobial Agents and Chemotherapy 56:4, pages 2153-2157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.